HROW Insider Trading
Insider Ownership Percentage: 13.67%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Harrow Share Price & Price History
Current Price: $24.67
Price Change: ▲ Price Increase of +0.02 (0.08%)
As of 04/29/2025 05:00 PM ET
Harrow Insider Trading History
Harrow Institutional Trading History
Data available starting January 2016
Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Read More on Harrow
Today's Range
Now: $24.67
52 Week Range
Now: $24.67
Volume
258,569 shs
Average Volume
502,822 shs
Market Capitalization
$879.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.46
Who are the company insiders with the largest holdings of Harrow?
Who are the major institutional investors of Harrow?
Harrow's top institutional shareholders include:
- Westside Investment Management Inc. — 0.49%
- Woodmont Investment Counsel LLC — 0.29%
- D.A. Davidson & CO. — 0.17%
- IMC Chicago LLC — 0.00%
- Rhumbline Advisers — 0.12%
- SG Americas Securities LLC — 0.08%
Learn More about top institutional investors of Harrow stock.
Which institutional investors are selling Harrow stock?
In the last quarter, HROW stock was sold by these institutional investors:
- Assenagon Asset Management S.A.
- SG Americas Securities LLC
- D.A. Davidson & CO.
- Teacher Retirement System of Texas
Which institutional investors are buying Harrow stock?
In the last quarter, HROW stock was acquired by institutional investors including:
- IMC Chicago LLC
- Woodmont Investment Counsel LLC
- Westside Investment Management Inc.
- GAMMA Investing LLC
- Rhumbline Advisers
Within the last year, these company insiders have bought Harrow stock:
- Opaleye Management Inc (Major Shareholder)
- Mark L Baum (CEO)
- Martin A Makary (Director)
Learn More investors buying Harrow stock.